SOGROYA

Google image searchProduct monograph

Active ingredient

somapacitan, 5 MG/1.5 ML

DIN: 02539934

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: PRE-FILLED PEN

Schedule: Prescription / Schedule D

Company: NOVO NORDISK CANADA INC

Date: 27-NOV-2023

ATC:

• H01 — PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, ATC/DDD, )
• H01A — ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES (ATC, ATC/DDD)
• H01AC — Somatropin and somatropin agonists (ATC, ATC/DDD)
• H01AC07 — SOMAPACITAN (ATC/DDD)

Reference brand drug: Sogroya

Pharmaceutical standard: MFR

External Links for Sogroya

Search on Google

• Sogroya side effects
• Sogroya dosage
• somapacitan side effects
• somapacitan dosage

Novo Nordisk Canada Inc

Go to Novo Nordisk website to see drug product details. Sometimes you can find sogroya photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.